SCOPUS 정보 검색 플랫폼

UPB Scientific Bulletin, Series B: Chemistry and Materials Science

Volumn 72, Issue 2, 2010, Pages 75-82

Synthesis of pyrazole derivatives, with biological activity in signal transduction therapy

(5) Miklós, Edina a Wáczek, Frigyes b Ker, György c Lányi, Szabolcs a Örfi, László c

a Faculty of Sciences (Romania)

b Vichem Chemie Ltd (Hungary)

c SEMMELWEIS UNIVERSITY (Hungary)

Author keywords

Heterocyclic molecule; Kinase inhibitor; Pyrazole derivatives

Indexed keywords

AMINE DERIVATIVES; BIOCHEMICAL ASSAY; BIOLOGICAL ACTIVITIES; CHEMICAL LIBRARIES; CHEMICAL SAMPLES; HETEROCYCLIC MOLECULES; HIGH-THROUGHPUT SCREENING; KINASE ASSAYS; KINASE INHIBITORS; MASS SPECTRA; MINOR COMPONENTS; PYRAZOLE DERIVATIVES; PYRAZOLES;

BIOACTIVITY; MASS SPECTROMETRY; MOLECULES; ORGANIC COMPOUNDS; SIGNAL TRANSDUCTION; THROUGHPUT;

ENZYME INHIBITION;

EID: 77953517680 PISSN: 14542331 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (1)

References (4)

1
- 33645095888
- Signal transduction therapy with rationally designed kinase inhibitors
- Gy.Kéri, L. Örfi, D.Erôs, B.Hegymegi-Barakonyi, C.Szántai-Kis, Z.Horváth, F.Wáczek, J.Marosfalvi, I.Szabadkai, J.Pató, Z.Greff, D.Hafenbradl, H.Daub, G.Müller, B.Klebl, A.Ullrich, Signal transduction therapy with rationally designed kinase inhibitors, Curr. Signal Transduct. Ther., 2006, vol. 1, no. 1, pp. 67-95
- (2006) Curr. Signal Transduct. Ther. , vol.1 , Issue.1 , pp. 67-95
- Kéri, G.¹ Örfi, L.² Erôs, D.³ Hegymegi-Barakonyi, B.⁴ Szántai-Kis, C.⁵ Horváth, Z.⁶ Wáczek, F.⁷ Marosfalvi, J.⁸ Szabadkai, I.⁹ Pató, J.¹⁰ Greff, Z.¹¹ Hafenbradl, D.¹² Daub, H.¹³ Müller, G.¹⁴ Klebl, B.¹⁵ Ullrich, A.¹⁶

2
- 77953483226
- Gy.Kéri, I.Tóth (eds.) Taylor & Francis Inc., London
- Gy.Kéri, I.Tóth (eds.), Molecular Pathomechanisms and New Trends in Drug Research, Taylor & Francis Inc., London, 2003, pp. 1-635
- (2003) Molecular Pathomechanisms and New Trends in Drug Research , pp. 1-635

3
- 0037019275
- Pyrazole urea-based inhibitors of p38 MAP kinase: From lead compound to clinical candidate
- J.Regan, S.Breitfelder, P.Cirillo, T.Gilmore, A.G. Graham, E.Hickey, B.Klaus, J.Madwed, M.Moriak, N.Moss, C.Pargellis, S.Pav, A.Proto, A.Swinamer, L.Tong, C.Torcellini, Pyrazole urea-based inhibitors of p38 MAP kinase: From lead compound to clinical candidate, J. Med. Chem., 2002, vol. 45, no. 14, pp. 2994-3008
- (2002) J. Med. Chem. , vol.45 , Issue.14 , pp. 2994-3008
- Regan, J.¹ Breitfelder, S.² Cirillo, P.³ Gilmore, T.⁴ Graham, A.G.⁵ Hickey, E.⁶ Klaus, B.⁷ Madwed, J.⁸ Moriak, M.⁹ Moss, N.¹⁰ Pargellis, C.¹¹ Pav, S.¹² Proto, A.¹³ Swinamer, A.¹⁴ Tong, L.¹⁵ Torcellini, C.¹⁶

4
- 77953510090
- Hungarian Patent Application, P0500912
- Zs.Székelyhidi, F.Wáczek, L.Õrfi, Gy.Kéri, Aromatic bicyclic (imidazo[4,5-c]pyrazole-5-yl)amine derivatives, their therapeutically accepted salts, pharmaceuticals containing them and method for their preparation, Hungarian Patent Application, P0500912
- Aromatic Bicyclic (Imidazo[4,5-c]pyrazole-5-yl)amine Derivatives, Their Therapeutically Accepted Salts, Pharmaceuticals Containing Them and Method for Their Preparation
- Székelyhidi, Z.¹ Wáczek, F.² Õrfi, L.³ Kéri, G.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.